Brooks Laboratories Ltd

Brooks Lab. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Brooks Laboratories Ltd

₹ 139 -1.98%
21 Nov 4:00 p.m.
brookslabs.net BSE: 533543 NSE: BROOKS
About

Incorporated in 2002, Brooks Laboratories Ltd is a pharmaceutical company working on contract basis catering to the critical care segment[1]

Key Points

Business Overview:[1]
BLL is an EU GMP & ISO 9001:2008 certified manufacturer and marketer of pharmaceutical formulations

Website BSE NSE - BE
  • Market Cap ₹ 365 Cr.
  • Current Price ₹ 139
  • High / Low ₹ 186 / 72.5
  • Stock P/E 224
  • Book Value ₹ 26.8
  • Dividend Yield 0.00 %
  • ROCE 3.45 %
  • ROE 2.41 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is expected to give good quarter

Cons

  • Stock is trading at 5.19 times its book value
  • The company has delivered a poor sales growth of 7.63% over past five years.
  • Company has a low return on equity of -3.32% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
21.05 18.12 21.31 14.94 15.89 12.00 12.61 15.70 24.32 21.75 17.72 17.93 20.79
19.86 19.72 20.98 18.98 16.16 13.47 12.74 15.67 22.60 20.66 17.34 17.65 19.28
Operating Profit 1.19 -1.60 0.33 -4.04 -0.27 -1.47 -0.13 0.03 1.72 1.09 0.38 0.28 1.51
OPM % 5.65% -8.83% 1.55% -27.04% -1.70% -12.25% -1.03% 0.19% 7.07% 5.01% 2.14% 1.56% 7.26%
0.34 0.22 0.37 0.05 0.07 0.06 0.03 0.05 0.09 0.16 0.65 0.07 0.20
Interest 0.12 0.13 0.23 0.16 0.19 0.24 0.18 0.17 0.19 0.21 0.27 0.16 0.32
Depreciation 0.35 0.36 0.42 0.42 0.43 0.43 0.44 0.44 0.44 0.43 0.46 0.40 0.43
Profit before tax 1.06 -1.87 0.05 -4.57 -0.82 -2.08 -0.72 -0.53 1.18 0.61 0.30 -0.21 0.96
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 4.92% 0.00% 0.00% 0.00%
1.06 -1.87 0.05 -4.57 -0.82 -2.08 -0.71 -0.53 1.18 0.58 0.30 -0.21 0.96
EPS in Rs 0.40 -0.71 0.02 -1.74 -0.31 -0.79 -0.27 -0.20 0.45 0.22 0.11 -0.08 0.37
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
80.11 85.27 85.21 80.01 57.54 55.71 55.03 69.69 76.66 76.97 55.54 79.49 78.19
69.61 76.75 78.36 68.93 52.50 64.64 63.40 72.27 75.65 75.10 61.36 76.28 74.93
Operating Profit 10.50 8.52 6.85 11.08 5.04 -8.93 -8.37 -2.58 1.01 1.87 -5.82 3.21 3.26
OPM % 13.11% 9.99% 8.04% 13.85% 8.76% -16.03% -15.21% -3.70% 1.32% 2.43% -10.48% 4.04% 4.17%
0.01 0.00 5.04 1.69 0.12 0.24 2.88 -0.94 0.90 0.95 0.12 0.96 1.08
Interest 0.11 0.12 0.44 0.79 1.01 2.40 2.96 3.35 3.25 0.67 0.77 0.84 0.96
Depreciation 0.81 0.83 1.10 1.16 1.67 6.45 6.50 6.65 7.09 1.49 1.72 1.77 1.72
Profit before tax 9.59 7.57 10.35 10.82 2.48 -17.54 -14.95 -13.52 -8.43 0.66 -8.19 1.56 1.66
Tax % 25.44% 4.36% 8.50% 1.66% 33.06% -21.21% -0.94% 80.33% 84.82% 0.00% 0.00% 1.92%
7.14 7.24 9.47 10.63 1.67 -13.81 -14.81 -24.38 -15.59 0.67 -8.18 1.53 1.63
EPS in Rs 2.87 2.91 3.80 4.27 0.67 -5.55 -5.95 -9.31 -5.95 0.26 -3.12 0.58 0.62
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: -1%
5 Years: 8%
3 Years: 1%
TTM: 21%
Compounded Profit Growth
10 Years: -14%
5 Years: 16%
3 Years: 28%
TTM: 176%
Stock Price CAGR
10 Years: 13%
5 Years: 41%
3 Years: 12%
1 Year: 10%
Return on Equity
10 Years: -6%
5 Years: -12%
3 Years: -3%
Last Year: 2%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 16.19 16.19 16.19 16.19 16.19 16.19 16.19 24.70 24.70 24.70 24.70 26.25 26.25
Reserves 89.22 96.10 95.23 105.86 112.09 98.29 88.96 73.71 39.51 40.30 32.08 43.28 44.03
1.09 0.14 0.51 5.71 13.72 27.98 31.18 27.64 8.40 5.97 6.51 5.64 8.99
25.16 20.04 23.61 24.77 22.13 30.21 31.55 31.81 20.39 32.48 29.13 19.22 22.92
Total Liabilities 131.66 132.47 135.54 152.53 164.13 172.67 167.88 157.86 93.00 103.45 92.42 94.39 102.19
20.65 20.15 15.68 16.34 125.95 124.64 117.70 113.02 14.96 15.14 15.01 13.67 14.57
CWIP 35.52 37.16 52.86 86.86 0.00 0.52 0.29 0.11 0.02 1.12 0.00 0.00 0.00
Investments 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 46.81 46.84 46.85 46.86 46.86
75.47 75.14 66.98 49.31 38.16 47.49 49.87 44.71 31.21 40.35 30.56 33.86 40.76
Total Assets 131.66 132.47 135.54 152.53 164.13 172.67 167.88 157.86 93.00 103.45 92.42 94.39 102.19

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
5.39 10.65 2.13 8.12 9.56 -6.18 -5.05 -9.39 -0.90 3.12 0.55 -9.68
-1.31 -10.64 -1.12 -13.56 -16.80 -5.14 1.12 -2.33 -0.74 1.12 -0.40 0.18
0.15 0.29 -0.07 4.32 7.01 11.82 5.78 9.61 1.31 -4.23 -0.21 9.60
Net Cash Flow 4.23 0.30 0.94 -1.12 -0.23 0.51 1.85 -2.10 -0.33 0.02 -0.06 0.10

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 98.78 70.46 82.63 86.27 67.81 66.70 75.75 81.50 45.66 71.27 83.79 74.94
Inventory Days 31.69 37.59 45.32 46.12 75.53 103.93 93.03 107.30 91.81 119.53 99.41 60.49
Days Payable 81.78 99.87 114.65 108.29 180.19 242.76 251.23 203.15 99.30 185.53 205.59 97.25
Cash Conversion Cycle 48.69 8.18 13.30 24.09 -36.85 -72.12 -82.45 -14.35 38.17 5.28 -22.39 38.18
Working Capital Days 85.57 29.45 43.82 23.13 -13.00 -20.97 -29.85 17.96 27.76 26.65 -3.81 57.81
ROCE % 9.76% 7.03% 7.24% 9.58% 2.59% -10.64% -8.72% -6.72% -5.15% 1.49% -11.07% 3.45%

Shareholding Pattern

Numbers in percentages

9 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
66.41% 66.41% 66.41% 66.41% 66.41% 66.41% 66.41% 63.59% 63.59% 63.59% 63.59% 63.59%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.02%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.46% 3.86% 3.86% 3.86% 3.86%
33.59% 33.59% 33.59% 33.58% 33.59% 33.59% 33.58% 33.94% 32.56% 32.55% 32.55% 32.53%
No. of Shareholders 10,91611,14511,10410,52410,41010,70911,21610,68610,02811,43211,54311,282

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Right Issue

Credit ratings